Anbio Biotechnology is a medical device firm specializing in in-vitro diagnostics, with recent stock volatility and a thin public float. I believe they continue to face significant regulatory hurdles ...
High-throughput techniques, such as automated chemiluminescent immunoassays (CLIAs), are essential in environments where thousands of analyses are performed daily. Consequently, the production volume ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510(k) clearance from the U.S. Food and ...
Anbio Biotechnology, a leader in in-vitro diagnostic technologies, announced its participation in three international exhibitions in May 2025: EuroMedLab in Brussels, AVA Conference in Sydney, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback